About this trial
The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilament needle examination), routine NCS, and the U/S of the median, posterior tibial, and sural nerves in identifying diabetic peripheral neuropathy in patients recently diagnosed with type 2 diabetes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ü Age: 30-55 y
Disqualifiers
Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.
Trial population
Place of study: Participants will be recruited from the diabetes clinic, Sohag university hospital. * Type of the study: Cross-Sectional Comparative study. * Patients: v Study group: participants of the study will meet the following criteria: Ø Inclusion criteria: ü Age: 30-55 y ü Type of diabetes: Type 2 ü Duration of diabetes: Within 1Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria ü Gender: Both males \& females Ø Exclusion criteria: Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Early detection of Diabetic Neuropathy
Utilizing the Michigan Neuropathy Screening Instrument, routine nerve conduction study, and nerve ultrasound for early detection of Diabetic Neuropathy
Sponsors and contacts
Click on the lead sponsor to view all of their trials.